Home / Pharma news / US FDA approves Novartis’ Rydapt

US FDA approves Novartis’ Rydapt

The US Food and Drug Administration (FDA) has approved Novartis’ Rydapt (midostaurin, formerly PKC412) for two indications.

Read more @ http://www.pharmabiz.com/NewsDetails.aspx?aid=101706&sid=2

Check Also

A Test that can spot all types of cancers in just 10 mins !

In a major breakthrough, scientists from the University of Queensland in Australia have claimed success ...

%d bloggers like this: